We are live on ! Find out more
CP

Corbenic Partners Portfolio holdings

AUM $380M
1-Year Est. Return 10.47%
This Fund
S&P 500
This Quarter Est. Return
+0.51%
1 Year Est. Return
-10.47%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$412M
AUM Growth
+$30.8M
Cap. Flow
+$30M
Cap. Flow %
7.28%
Top 10 Hldgs %
67.78%
Holding
312
New
49
Increased
64
Reduced
28
Closed
22

Sector Composition

Rank Sector Weight
1 Technology 11.17%
2 Consumer Discretionary 7.31%
3 Healthcare 5.06%
4 Communication Services 3.64%
5 Utilities 3.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REAL icon
301
The RealReal
REAL
$1.34B
$0 ﹤0.01%
25
RTX icon
302
RTX Corp
RTX
$287B
-100
Closed -$9K
SLB icon
303
SLB Ltd
SLB
$77.8B
$0 ﹤0.01%
14
STLD icon
304
Steel Dynamics
STLD
$35.6B
$0 ﹤0.01%
1
TRMB icon
305
Trimble
TRMB
$12.3B
-75
Closed -$6K
VIGI icon
306
Vanguard International Dividend Appreciation ETF
VIGI
$8.89B
$0 ﹤0.01%
5
MUDS
307
DELISTED
Mudrick Capital Acquisition Corporation II Class A Common Stock
MUDS
-100
Closed -$1K
MILE
308
DELISTED
Metromile, Inc. Common Stock
MILE
$0 ﹤0.01%
130
CERN
309
DELISTED
Cerner Corp
CERN
-144
Closed -$11K
WORK
310
DELISTED
Slack Technologies, Inc.
WORK
-319
Closed -$14K
VAL
311
DELISTED
Valaris plc Class A Ordinary Share
VAL
$0 ﹤0.01%
10
SFXE
312
DELISTED
SFX ENTERTAINMENT, INC COM
SFXE
$0 ﹤0.01%
1,950

Similar funds

Corbenic Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Corbenic Partners held 312 positions worth $412M, up 8.1% from $382M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Corbenic Partners deployed $30M of net new capital in Q3 2021, opening 49 new positions and adding to 64 existing holdings. Its largest new stake was Moderna: 64 shares worth $25K.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Pfizer, an estimated $288K trimmed.

  • Corbenic Partners's largest Q3 2021 buy was Moderna: 64 shares worth $25K.
  • Corbenic Partners added most to iShares Core Dividend Growth ETF in Q3 2021, an estimated $5.61M increase.
  • Corbenic Partners's biggest Q3 2021 reduction was Pfizer, cutting an estimated $288K.
  • Corbenic Partners fully exited Global X MSCI Greece ETF in Q3 2021, selling an estimated $85K.
  • Corbenic Partners's ten largest holdings make up 68% of its $412M portfolio in Q3 2021.
  • Corbenic Partners opened 49 new positions and closed 22 in Q3 2021.
  • Corbenic Partners's portfolio value rose 8.1% quarter-over-quarter to $412M.

Based on Corbenic Partners's 13F filing for Q3 2021, filed 13 Oct 2021.